Risk of serious infection, opportunistic infection and herpes zoster among patients with psoriasis in the United Kingdom

Por Takeshita, Junko, Shin, Daniel B., Ogdie, Alexis, Gelfand, Joel M.
Publicado no J Invest Dermatol (2018)

Racial and ethnic differences in healthcare utilization for childhood eczema: an analysis of the 2001–2013 Medical Expenditure Panel Surveys

Por Fischer, Alexander H., Shin, Daniel B., Margolis, David J., Takeshita, Junko
Publicado no J Am Acad Dermatol (2017)

Healthcare utilization for psoriasis in the United States differs by race: an analysis of the 2001–2013 Medical Expenditure Panel Surveys

Por Fischer, Alexander H., Shin, Daniel B., Gelfand, Joel M., Takeshita, Junko
Publicado no J Am Acad Dermatol (2018)

The Risk of Cancer in Patients With Psoriasis: A Population-Based Cohort Study in the Health Improvement Network

Por Chiesa Fuxench, Zelma C., Shin, Daniel B., Beatty, Alexis Ogdie, Gelfand, Joel M.
Publicado no JAMA Dermatol (2016)

How similar are treatment responses to biosimilars in psoriasis patient? A systematic review of statistical margins in comparative clinical trials

Por Wan, Marilyn T., Strober, Bruce E., Wu, Jashin J., Shin, Daniel B., Gelfand, Joel M.
Publicado no J Am Acad Dermatol (2017)

Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study

Por Wan, Joy, Wang, Shuwei, Haynes, Kevin, Denburg, Michelle R, Shin, Daniel B, Gelfand, Joel M
Publicado em 2013

Dermatologist response rates to a mailed questionnaire: a randomized trial of monetary incentives

Por Wan, Joy, Abuabara, Katrina, Shin, Daniel B., Troxel, Andrea B., Bebo, Bruce F., Gelfand, Joel M.
Publicado em 2011

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

Por Mehta, Nehal N., Azfar, Rahat S., Shin, Daniel B., Neimann, Andrea L., Troxel, Andrea B., Gelfand, Joel M.
Publicado em 2010

Increased Risk of Diabetes and Likelihood of Receiving Diabetes Treatment in Patients with Psoriasis

Por Azfar, Rahat S., Seminara, Nicole M., Shin, Daniel B., Troxel, Andrea B., Margolis, David J., Gelfand, Joel M.
Publicado em 2012

Psoriasis and the Risk of Diabetes: A Prospective Population-Based Cohort Study

Por Wan, Marilyn T., Shin, Daniel B., Hubbard, Rebecca A., Noe, Megan H., Mehta, Nehal N., Gelfand, Joel M.
Publicado no J Am Acad Dermatol (2017)

The Risk of Stroke in Patients with Psoriasis

Por Gelfand, Joel M., Dommasch, Erica, Shin, Daniel B, Azfar, Rahat S., Kurd, Shanu Kohli, Wang, Xingmei, Troxel, Andrea B.
Publicado em 2009

Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events

Por Mehta, Nehal N., Yu, YiDing, Pinnelas, Rebecca, Krishnamoorthy, Parasuram, Shin, Daniel B., Troxel, Andrea B., Gelfand, Joel M.
Publicado em 2011

Effect of Psoriasis Severity on Hypertension Control: A Population-Based Study in the United Kingdom

Por Takeshita, Junko, Wang, Shuwei, Shin, Daniel B., Mehta, Nehal N., Kimmel, Stephen E., Margolis, David J., Troxel, Andrea B., Gelfand, Joel M.
Publicado no JAMA Dermatol (2015)

Patient-Reported Outcomes in Psoriasis Patients with Clear Versus Almost Clear Skin in the Clinical Setting

Por Takeshita, Junko, Duffin, Kristina Callis, Shin, Daniel B., Krueger, Gerald G., Robertson, Andrew D., Troxel, Andrea B., Van Voorhees, Abby S., Gelfand, Joel M.
Publicado em 2014

Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom

Por Langan, Sinéad M., Seminara, Nicole M., Shin, Daniel B., Troxel, Andrea B., Kimmel, Stephen E., Mehta, Nehal N., Margolis, David J., Gelfand, Joel M.
Publicado em 2011

A prospective clinical trial of open label etanercept for the treatment of hidradenitis suppurativa

Por Lee, Robert A., Dommasch, Erica, Treat, James, Sciacca-Kirby, Joslyn, Chachkin, Samuel, Williams, Jennifer, Shin, Daniel B, Leyden, James J., Vittorio, Carmela, Gelfand, Joel M.
Publicado em 2009

Dermatologist preferences for first-line therapy of moderate-to-severe psoriasis in healthy adult patients

Por Wan, Joy, Abuabara, Katrina, Troxel, Andrea B., Shin, Daniel B., Van Voorhees, Abby S., Bebo, Bruce F., Krueger, Gerald G., Duffin, Kristina Callis, Gelfand, Joel M.
Publicado em 2011

Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate-to-severe psoriasis

Por Wan, Joy, Abuabara, Katrina, Troxel, Andrea B., Shin, Daniel B., Van Voorhees, Abby S., Bebo, Bruce F., Krueger, Gerald G., Duffin, Kristina Callis, Gelfand, Joel M.
Publicado em 2012

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate-to-severe psoriasis

Por Abuabara, Katrina, Wan, Joy, Troxel, Andrea B., Shin, Daniel B., Van Voorhees, Abby S., Bebo, Bruce F., Krueger, Gerald G., Duffin, Kristina Callis, Gelfand, Joel M.
Publicado em 2012

Psoriasis severity and the prevalence of major medical co-morbidities: a population-based study

Por Yeung, Howa, Takeshita, Junko, Mehta, Nehal N., Kimmel, Stephen E., Ogdie, Alexis, Margolis, David J., Shin, Daniel B., Attor, Rosemary, Troxel, Andrea B., Gelfand, Joel M.
Publicado em 2013